SJS Investment Consulting’s Exelon EXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.7K Sell
379
-439
-54% -$20.3K ﹤0.01% 837
2026
Q1
$40.1K Buy
818
+17
+2% +$791 ﹤0.01% 466
2025
Q4
$34.9K Buy
801
+490
+158% +$22.4K ﹤0.01% 476
2025
Q3
$14K Buy
311
+289
+1,314% +$12.7K ﹤0.01% 576
2025
Q2
$956 Sell
22
-24
-52% -$1.07K ﹤0.01% 873
2025
Q1
$2.12K Buy
46
+15
+48% +$627 ﹤0.01% 703
2024
Q4
$1.17K Sell
31
-13
-30% -$504 ﹤0.01% 942
2024
Q3
$1.78K Buy
44
+4
+10% +$150 ﹤0.01% 841
2024
Q2
$1.39K Sell
40
-1
-2% -$37 ﹤0.01% 893
2024
Q1
$1.54K Sell
41
-1
-2% -$36 ﹤0.01% 872
2023
Q4
$1.51K Sell
42
-5
-11% -$193 ﹤0.01% 783
2023
Q3
$1.78K Buy
47
+19
+68% +$774 ﹤0.01% 688
2023
Q2
$1.14K Sell
28
-9
-24% -$372 ﹤0.01% 844
2023
Q1
$1.55K Hold
37
﹤0.01% 683
2022
Q4
$1.6K Buy
37
+4
+12% +$158 ﹤0.01% 731
2022
Q3
$2K Buy
+33
New +$1.46K ﹤0.01% 457
2022
Q1
$0 Buy
+4
New +$169 ﹤0.01% 891

Other funds holding EXC

SJS Investment Consulting's EXC Position: Q2 2026 in Review

SJS Investment Consulting reduced its Exelon (EXC) stake by 54% in Q2 2026, selling an estimated $20.3K and leaving 379 shares worth $17.7K. The position accounts for ﹤0.01% of the portfolio, ranked #837.

SJS Investment Consulting first reported a position in EXC in Q1 2022 and has held it in 17 quarters since. The position peaked at $40.1K in Q1 2026. 823 funds tracked by Wall St. Rank hold EXC as of Q2 2026.

  • SJS Investment Consulting held 379 shares of Exelon worth $17.7K as of Q2 2026.
  • SJS Investment Consulting sold 439 Exelon shares in Q2 2026, an estimated $20.3K.
  • Exelon made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #837 holding.
  • SJS Investment Consulting first reported a position in Exelon in Q1 2022 and has held it in 17 quarters since.
  • SJS Investment Consulting's Exelon position peaked at $40.1K in Q1 2026.
  • 823 funds tracked by Wall St. Rank held Exelon as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.